- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- September 2025
- 150 Pages
Global
From €3907EUR$4,450USD£3,380GBP
- Report
- September 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- September 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- June 2025
- 150 Pages
Global
From €3380EUR$3,850USD£2,924GBP
€4258EUR$4,850USD£3,684GBP
- Report
- April 2025
- 199 Pages
Global
From €4385EUR$4,995USD£3,794GBP
- Report
- March 2025
- 240 Pages
Global
From €4385EUR$4,995USD£3,794GBP
- Report
- November 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- November 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- November 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- October 2025
- 160 Pages
Global
From €3468EUR$3,950USD£3,000GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more